Hims & Hers Super Bowl ad sparks weight-loss drug backlash
(NewsNation) — Telehealth company Hims & Hers is being called out over its Super Bowl ad going after Big Pharma and popular weight-loss injections.
The ad highlights compounded versions of the drugs, which are cheaper than brand-name alternatives like Novo Nordisk's Wegovy and Ozempic.
It also touts a non-FDA-approved Hims & Hers weight-loss drug as the supreme and affordable solution to America's obesity epidemic and has sparked backlash for perceived fat-shaming and political pandering.
Critics argue that while Hims & Hers criticizes the nation's food corporations and health care as greedy and broken, the company itself is part of the problem, leaving out crucial health risks and dangerous side effects.
Dr. Heather Hirsch, a board-certified internist, warns that compounded medications can be risky and lack the rigorous FDA approval process of brand-name drugs.
Flu activity highest in 15 years: Which states have it worst?
'When we start compounding things and we remove some of the regulation, it is a little bit of the wild, wild west. Now, we could say 95% of it is going to be safe and effective, but would you want to be the one person who gets the vial that's not? And there's been cases of meningitis. There's been cases of bacterial infections from compounded pharmacies because these medications don't carry the same approval or rigorous process that FDA-approved medications do,' Hirsch said.
The Hims & Hers version of the weight-loss drug is a compounded drug, essentially a mixture of individual drugs that creates a near copy of the brand versions. It's currently allowed to skirt FDA regulations and avoid the strict approval processes that big-name drugs like Ozempic, Wegovy and Monjaro undergo.
'With every batch of semaglutide that they produce, there's something called the certificate of analysis CoA, and that CoA does somewhere between 10 and 15 tests,' Dr. Craig Primack, the head of weight management at Hims & Hers said. 'To give you confidence that what you're getting is the compounded drug and it does not have contaminants.'
Hims & Hers stands by its safety protocols, emphasizing patient care and accessibility.
A doctor from the company told NewsNation they defended its compounded drugs, claiming they undergo testing for safe concentration levels and viruses and bacteria.
Nearly everyone in the world breathes bad air. How to lower your risk
Hims & Hers said it is following the law, cares about its patients, and believes its drug is helping Americans with 'both access and affordability.'
In response, Ozempic and Wegovy have published full-page ads questioning the safety of the compounded drugs.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
20 minutes ago
- New York Post
Average penis size has increased — and Ozempic could be to blame, experts say
Ozempic might shrink waistlines, but it seems to bulge another body part. In a recent Reddit thread, male Ozempic users claimed that the weight-loss drugs helped their penises grow. 'I recently measured myself down there and noticed I gained about one inch,' a person proudly shared on the forum. Advertisement Although there hasn't been enough research done on the correlation between semaglutide and men's genitalia measurements — the average penis size is continuing to rise, and some experts think Ozempic might actually have something to do with it. The average penis has grown nearly 10% from 5.17 inches to 5.63 between 2022 and 2024 in the UK, according to And they're not the only ones seeing this increase. Advertisement The data also revealed that Venezuelan men experienced a massive increase from 1.42 inches to 6.67 inches, within those two years. Dr. Richard Viney, a consultant urological surgeon at the Queen Elizabeth Hospital in Birmingham, thinks Ozempic and similar drugs could be to blame. 'Men's penises shorten as they get older (due to) increasing body fat and increasing prostate size drawing the penis back into the body,' he told Dr. Richard Viney thinks weight-loss drugs, like Ozempic could be to blame for increased penis size. Christopher Sadowski Advertisement 'It is theoretically possible that new drugs like Ozempic and Wegovy, which are used to treat diabetes and obesity, respectively and can cause people to lose weight, could also be a factor. As men lose weight, their penises appear larger.' However, in 2023, research published in the World Journal of Men's Health revealed that the average size of what a guy is packing has grown 24% over nearly 30 years. And that sort of increase has health experts concerned — especially because even two years ago, they couldn't put their finger on what the cause of it is. Advertisement Speculation around weight loss drugs being the culprit is possible — but the Ozempic trend is recent, and this growth for men has clearly been going on for some time now. 'Any overall change in development is concerning, because our reproductive system is one of the most important pieces of human biology,' Dr. Michael Eisenberg, the study's author, told Stanford Medicine's blog Scope. 'If we're seeing this fast of a change, it means that something powerful is happening to our bodies.' Other possible causes could be chemical exposure from pesticides or hygiene products, Eisenberg hypothesized, which can disrupt the hormone-regulating endocrine system. Time will only tell if Ozempic or other lifestyle factors are to blame for well-endowed men.
Yahoo
39 minutes ago
- Yahoo
These Popular Eggs Are Being Recalled Over Salmonella Risk
If you've been living for your morning sunny-side eggs…well, brace yourself. The August Egg Company—the parent behind Sunnyside, Clover, Raley's, and a few other brands—is recalling a whopping 1.7 million dozen eggs due to a potential salmonella outbreak. Yep, it's serious.. The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention have flagged the August Company's 'brown cage-free and brown certified organic egg' for possible contamination, meaning you might want to double-check that carton in your fridge before cracking it open. If you didn't know, Salmonella is that sneaky bacteria behind food poisoning and can cause anything from mild stomach upset to serious illness. These eggs were shipped to Walmart stores and other grocers in nine states: California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and Illinois. They have a best-by date from March 4 to June 19 and food codes P-6562 or CA5330. Not sure if your eggs are on the list? The FDA has a full rundown of all the recalled brands you can check out. And if the cartons in your fridge match any of the food codes or best-by-dates, toss them out immediately. While it's somewhat okay to eat an egg past its expiration date, this isn't the case. The FDA has already connected a current salmonella outbreak to the eggs. As of now, a total of 79 cases have been reported in seven states, while 21 people have been hospitalized. We get it: eggs are pricey, and tossing them feels like a waste. But don't risk it. Plus, most places will give you a full refund. And if your eggs touched any surfaces, wipe those down like your life depends on it. If after eating you feel dizzy, nauseous, or get a fever—don't play it cool. Call your doctor. This is serious business. Trust me, as a four-time survivor of food poisoning, you don't want to take any chances. You Might Also Like Insanely Easy Weeknight Dinners To Try This Week 29 Insanely Delicious Vodka Cocktails
Yahoo
3 hours ago
- Yahoo
AG pushes back on federal abortion medication restrictions
BOSTON (SHNS) – Attorney General Andrea Campbell implored federal regulators Thursday to eliminate medication abortion restrictions on prescribers and pharmacies, arguing Massachusetts already has 'robust' guardrails in place to protect patient safety. Campbell, along with AGs from California, New York and New Jersey, want the U.S. Food and Drug Administration to eliminate its Risk Evaluation and Mitigation Strategy (REMS) program for mifepristone — or at least stop applying certain parts of it to the four petitioning states. The program outlines certification requirements for health care providers and pharmacies to dispense mifepristone, plus paperwork that patients must sign. About 65% of abortions in Massachusetts in 2023 were medication abortions, according to the 64-page citizen petition Campbell co-filed Thursday. The FDA says REMS programs are used for drugs with 'serious safety concerns to help ensure the benefits of the medication outweigh its risks.' Campbell's office contends the mifepristone requirements impose 'burdensome restrictions on access to medication abortion while not meaningfully improving patient safety, and that these restrictions severely impede patient access by reducing the number of prescribers and pharmacies authorized to dispense this FDA-approved medication.' 'The Mifepristone REMS Program also imposes an undue burden on pregnant patients experiencing miscarriage and early pregnancy loss who seek treatment at emergency departments,' the petition says. 'For instance, the administrative requirements imposed by the REMS can effectively discourage emergency departments from carrying mifepristone in their pharmacies.' Reduced access to mifepristone can particularly impact patients in rural and medically underserved areas, the petition added. The Democratic AGs teamed up in response to U.S. Health and Human Services Secretary Robert Kennedy recently instructing FDA Commissioner Martin Makary to pursue a 'complete review' of mifepristone and labeling requirements. The FDA is required to respond to their petition within 180 days by either approving, denying or dismissing it — or providing a 'tentative response' about why the agency is unable to reach a decision yet, according to federal regulations. In response to the Trump administration, Beacon Hill lawmakers are escalating their focus on shoring up protections for reproductive and transgender care. A Sen. Cindy Friedman bill (S 2522) that's gaining traction would tighten the 2022 abortion shield law, including by requiring hospitals to provide emergency abortion care and allowing provider practices, rather than specific prescriber names, to appear on medication abortion labels. WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
